Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;6(1):23-7.
doi: 10.1111/os.12093.

Metabolic syndrome increases the prevalence of spine osteoarthritis

Affiliations

Metabolic syndrome increases the prevalence of spine osteoarthritis

Rajiv Gandhi et al. Orthop Surg. 2014 Feb.

Abstract

Objective: To determine whether the prevalence of severe spinal osteoarthritis (OA) increases with the number of metabolic syndrome (MetS) risk factors.

Methods: Data from a single surgeon's high volume, spine surgery practice were reviewed. Severe OA was defined as degenerative spondylolisthesis or cervical or lumbar stenosis causing neurologically based symptoms and early OA as lumbar and cervical spondylosis causing axial pain only. Logistic regression modeling was used to determine the odds (adjusted for age and sex) of having severe spine OA with more numerous MetS risk factors.

Results: Severe spinal OA was identified in 839/1502 patients (55.9%) and early OA in the remaining 663 individuals (44.1%). The overall prevalence of MetS was 30/1502 (2.0%): 26/839 (3.1%) in the severe OA group and 4/663 (0.6%) in the early OA group (P = 0.001). Presence of all four MetS risk factors was associated with almost quadruple the odds of having severe OA as compared with absence of risk factors (OR 3.9 [1.4-11.6], P < 0.01).

Conclusion: The components of MetS are more prevalent in subjects with severe spinal OA than in those with spondylosis causing axial pain. Future study of the association between MetS and the incidence of OA is required.

Keywords: Metabolic syndrome; Obesity; Osteoarthritis; Spine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Odds ratios for the prevalence of severe spinal osteoarthritis by number of metabolic syndrome risk factors compared to controls.

Similar articles

Cited by

References

    1. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab, 2004, 89: 2595–2600. - PubMed
    1. Yaffe K, Kanaya A, Lindquist K, et al The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, 2004, 292: 2237–2242. - PubMed
    1. Aspden RM, Scheven BA, Hutchison JD. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet, 2001, 357: 1118–1120. - PubMed
    1. Conaghan PG, Vanharanta H, Dieppe PA. Is progressive osteoarthritis an atheromatous vascular disease? Ann Rheum Dis, 2005, 64: 1539–1541. - PMC - PubMed
    1. Dumond H, Presle N, Terlain B, et al Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum, 2003, 48: 3118–3129. - PubMed